Inhibition of nNOS reduces ischemic cell death through down-regulating calpain and caspase-3 after experimental stroke

Neurochemistry International

Volumn 54, Issue 5-6, 2009, Pages 339-346

  Sun, Ming ^a   Zhao, Yumei ^a   Gu, Yi ^a   Xu, Chao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Calpain; Caspase 3; Experimental stroke; Necrosis; Neuronal nitric oxide synthase

Indexed keywords

7 NITROINDAZOLE; CALPAIN; CASPASE 3; MICROTUBULE ASSOCIATED PROTEIN 2; NEURONAL NITRIC OXIDE SYNTHASE; SPECTRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; ENZYME INHIBITION; HISTOPATHOLOGY; MALE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; STROKE;

ANIMALS; APOPTOSIS; BRAIN EDEMA; CALPAIN; CASPASE 3; CELL DEATH; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; HYPOXIA-ISCHEMIA, BRAIN; INDAZOLES; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NECROSIS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; RATS; RATS, SPRAGUE-DAWLEY; SPECTRIN; STROKE;

RATTUS;

EID: 61449215012     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.12.017     Document Type: Article

References (58)

1. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 Pt 3 (2001) 593-615
2. Araújo I.M., Ambrósio A.F., Leal E.C., Santos P.F., Carvalho A.P., and Carvalho C.M. Neuronal nitric oxide synthase proteolysis limits the involvement of nitric oxide in kainate-induced neurotoxicity in hippocampal neurons. J. Neurochem. 85 (2003) 791-800
3. Ashwal S., Tone B., Tian H.R., Cole D.J., and Pearce W.J. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 29 (1998) 1037-1047
4. Babbedge R.C., Bland-Ward P.A., Hart S.L., and Moore P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol. 110 (1993) 225-228
5. Benchoua A., Guegan C., Couriaud C., Hosseini H., Sampaio N., Morin D., and Onteniente B. Specific caspase pathways are activated in the two stages of cerebral infarction. J. Neurosci. 21 (2001) 7127-7134
6. Bennett V. Spectrin: a structural mediator between diverse plasma membrane proteins and the cytoplasm. Curr. Opin. Cell. Biol. 2 (1990) 51-56
7. 2+ signals and death programmes in neurons. Phil. Trans. R. Soc. B. 360 (2005) 2255-2258
8. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., and Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7162-7166
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
10. Choi B.M., Pae H.O., Jang S.I., Kim Y.M., and Chung H. Nitric oxide as an apoptotic as well as anti-apoptotic modulator. J. Biochem. Mol. Boil. 35 (2002) 116-126
11. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., and Kim Y.M. Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Commun. 282 (2001) 1075-1079
12. Dawson D.A., and Hallenbeck J.M. Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J. Cereb. Blood Flow Metab. 16 (1996) 170-174
13. Dong, Y., Wu, Y., Wu, M., Wang, S., Zhang, J., Xie, Z., Xu, J., Song, P., Wilson, K., Zhao, Z., Lyons, T., Zou, M.H., Activation of protease calpain by oxidized and glycated LDL increases the degradation of endothelial nitric oxide synthase. J. Cell. Mol. Med (in press).
14. Escott K.J., Beech J.S., Haga K.K., Williams S.C., Meldrum B.S., and Bath P.M. Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18 (1998) 281-287
15. Fink K., Zhu J., Namura S., Shimizu-Sasamata M., Endres M., Ma J., Dalkara T., Yuan J., and Moskowitz M.A. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J. Cereb. Blood Flow Metab. 18 (1998) 1071-1076
16. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119 (1992) 493-501
17. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
18. Goodman S.R., and Zagon I.S. The neural cell spectrin skeleton: a review. Am. J. Physiol. 250 (1986) C347-C360
19. Ha S.K., Lee P., Park J.A., Oh H.R., Lee S.Y., Park J.H., Lee E.H., Ryu J.H., Lee K.R., and Kim S.Y. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem. Int. 52 (2008) 878-886
20. Hamakubo T., Kannagi R., Murachi T., and Matus A. Distribution of calpains I and II in rat brain. J. Neurosci. 6 (1986) 3103-3111
21. Harwood S.M., Yaqoob M.M., and Allen D.A. Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis. Ann. Clin. Biochem. 42 (2005) 415-431
22. Holtz M.L., Craddock S.D., and Pettigrew L.C. Rapid expression of neuronal and inducible nitric oxide synthases during post-ischemic reperfusion in rat brain. Brain Res. 898 (2001) 49-60
23. Huang P.L. Neuronal and endothelial nitric oxide synthase gene knockout mice. Braz. J. Med. Biol. Res. 32 (1999) 1353-1359
24. Iadecola C., Zhang F., Xu S., Casey R., and Ross M.E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab. 15 (1995) 378-384
25. Johnson G.V., Litersky J.M., and Jope R.S. Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J. Neurochem. 56 (1991) 1630-1638
26. Juin P., Pelletier M., Oliver L., Tremblais K., Gregoire M., Meflah K., and Vallette F.M. Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J. Biol. Chem. 273 (1998) 17559-17564
27. Kambe A., Yokota M., Saido T.C., Satokata I., Fujikawa H., Tabuchi S., Kamitani H., and Watanabe T. Spatial resolution of calpain-catalyzed proteolysis in focal cerebral ischemia. Brain Res. 1040 (2005) 36-43
28. Kim J.S., He L., and Lemasters J.J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 463-470
29. Kone B.C., Kuncewicz T., Zhang W., and Yu Z.Y. Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am. J. Physiol. Renal. Physiol. 285 (2003) F178-F190
30. Kristian T., and Siesjo B.K. Calcium in ischemic cell death. Stroke 29 (1998) 705-718
31. Li J., Grynspan F., Berman S., Nixon R., and Bursztajn S. Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord. J. Neurobiol. 30 (1996) 177-191
32. Lin T.N., He Y.Y., Wu G., Khan M., and Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24 (1993) 117-121
33. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79 (1999) 1431-1568
34. Ludin B., and Matus A. The neuronal cytoskeleton and its role in axonal and dendritic plasticity. Hippocampus 3 (1993) 61-71
35. Marcoux F.W., Morawetz R.B., Crowell R.M., DeGirolami U., and Halsey Jr. J.H. Differential regional vulnerability in transient focal cerebral ischemia. Stroke 13 (1982) 339-346
36. Minger S.L., Geddes J.W., Holtz M.L., Craddock S.D., Whiteheart S.W., Siman R.G., and Pettigrew L.C. Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia. Brain Res. 81 (1998) 181-199
37. Moncada S., and Balanos J.P. Nitric oxide, cell bioenergetics and neurodegeneration. J. Neurochem. 97 (2006) 1676-1689
38. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., and Hart S.L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol 108 (1993) 296-297
39. Nath R., Raser K.J., Stafford D., Hajimohammadreza I., Posner A., Allen H., Talanian R.V., Yuen P., Gilbertsen R.B., and Wang K.K. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319 (1996) 683-690
40. Osawa Y., Lowe E.R., Everett A.C., Dunbar A.Y., and Billecke S.S. Proteolytic degradation of nitric oxide synthase: effect of inhibitors and role of hsp90-based chaperones. J. Pharmacol. Exp. Ther. 304 (2003) 493-497
41. Panickar K.S., and Norenberg M.D. Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 50 (2005) 287-298
42. Prast H., and Philippu A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64 (2001) 51-68
43. Rami A., Volkmann T., Agarwal R., Schoninger S., Nurnberger F., Saido T.C., and Winckler J. beta2-Adrenergic receptor responsiveness of the calpain-calpastatin system and attenuation of neuronal death in rat hippocampus after transient global ischemia. Neurosci. Res. 47 (2003) 373-382
44. Raser K.L., Posner A., and Wang K.K. Casein zymography: a method to study μ-calpain, m-calpain and their inhibitory agents. Arch. Biochem. Biophys. 319 (1995) 211-216
45. Samdani A.F., Dawson T.M., and Dawson V.L. Nitric oxide synthase in models of focal ischemia. Stroke 28 (1997) 1283-1288
46. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., and Reulen H.J. A critical reevalution of the intraluminal thread model of focal cerebral ischemia. Evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke 29 (1998) 2162-2170
47. Sun M., and Xu C. Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia. Cell. Mol. Neurobiol. 28 (2008) 593-611
48. Sun M., Zhao Y., and Xu C. Cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion. Cell. Mol. Neurobiol. 28 (2008) 71-85
49. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., and Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10 (1990) 290-293
50. Ueda H., and Fujita R. Cell death mode switch from necrosis to apoptosis in brain. Biol. Pharm. Bull. 27 (2004) 950-955
51. Valeriani V., Dewar D., and McCulloch J. Quantitative assessment of ischemic pathology in axons, oligodendrocytes, and neurons: attenuation of damage after transient ischemia. J. Cereb. Blood Flow Metab. 20 (2000) 765-771
52. Walker G., Pfeilschifter J., Otten U., and Kunz D. Proteolytic cleavage of inducible nitric oxide synthase (iNOS) by calpain I. Biochim. Biophys. Acta 1568 (2001) 216-224
53. Wang K.K. Calpain and caspase: can you tell the difference?. Trends Neurosci. 23 (2000) 20-26
54. Wang X., Ryter S.W., Dai C., Tang Z.L., Watkins S.C., Yin X.M., Song R., and Choi A.M. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J. Biol. Chem. 278 (2003) 29184-29191
55. Willmot M., Gibson C., Gray L., Murphy S., and Bath P. Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic. Biol. Med. 39 (2005) 412-425
56. Wiltrout C., Lang B., Yan Y., Dempsey R.J., and Vemuganti R. Repairing brain after stroke: a review on post-ischemic neurogenesis. Neurochem. Int. 50 (2007) 1028-1041
57. Yoshida T., Limmroth V., Irikura K., and Molkowitz M.A. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab 14 (1994) 924-929
58. Zhao X., Haensel C., Araki E., Ross M.E., and Iadecola C. Gene-dosing effect and persistence of reduction in ischemic brain injury in mice lacking inducible nitric oxide synthase. Brain Res. 872 (2000) 215-218